文献速递鼻科

成人鼻出血住院管理的全国前瞻性观察研究——由全国受训者研究协作组实施

National prospective observational study of inpatient management of adults with epistaxis - a National Trainee Research Collaborative delivered investigation.
PubMed 文献 · Rhinology · 2019-01-01

该研究基于2016年英国113家医院30天全国多中心前瞻性审计数据,二次分析1402例因鼻出血住院成人中834例资料完整者,评估专科治疗对严重鼻出血成功管理的影响。首次专科查体未行鼻腔烧灼者治疗时间较烧灼者延长逾一倍(校正比值2.5,95%CI 1.7-3.3),仅30%患者管理符合新国家指南,符合者止血可能性高87%,治疗类型不影响30天再就诊。

要点

  • 首次专科查体未行鼻腔烧灼者治疗时间较烧灼者延长逾一倍(校正比值2.5,95%CI 1.7-3.3)。
  • 仅30%患者管理符合新国家指南,符合者止血可能性高87%。
  • 初始干预或管理策略类型不影响30天再就诊率。

核心结论

  • 分析全国审计数据提示,首次专科查体时行烧灼及按国家指南管理可缩短住院治疗时间,且不增加30天再就诊。
  • 未来工作应探究早期鼻腔烧灼使用率低的原因,以及如何优化服务提供以广泛实施循证管理。

研究设计与样本

  • 对2016年30天全国多中心审计中鼻出血患者资料进行二次分析,数据前瞻性录入,出院后随访30天。
  • 113家英国参与医院共识别1402例因鼻出血住院管理的成人,834例资料足够纳入分析。
  • 评估暴露变量包括首次耳鼻咽喉科查体时启动的治疗、住院期间干预策略、疾病因素、患者危险因素及治疗因素;主要结局为治疗时间及30天再入院率。

主要发现

  • 首次专科查体未行鼻腔烧灼者治疗时间较烧灼者延长逾一倍:校正比值2.5(95%CI 1.7-3.3),校正年龄、出血严重度及是否行鼻腔填塞。
  • 仅30%患者管理符合新国家指南,符合者止血可能性较不符合者高87%,校正出血严重度后仍如此。
  • 初始干预或管理策略类型不影响30天再就诊。

局限性

  • 原文指出既往鼻出血干预研究样本量小,缺乏独立于病情严重度或额外干预分析干预效果的效能。
  • 原文结论提出未来工作应探究早期鼻腔烧灼使用率低的原因及优化服务提供以广泛实施循证管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a paucity of high-quality evidence relating to the management of epistaxis severe enough to require admission to a hospital. Previous studies of interventions for epistaxis have suffered from small sample sizes. They lacked the power to allow analysis of the effect of an intervention on epistaxis control that is independent of the condition severity or additional interventions given. OBJECTIVE: To determine the effect of specialist treatments on the successful management of severe epistaxis METHODOLOGY: Secondary analysis of data collected from a national multi-centre audit of patients with epistaxis over 30 days in 2016. Data were entered prospectively, and patients were followed up for 30 days following hospital discharge. 1402 adults admitted for inpatient management of epistaxis were identified in 113 participating UK hospitals, with data entered prospectively during the 30-day audit window. Exposure variables assessed included treatment instigated at first ENT review, intervention strategy during hospitalization, disease factors (e.g. severity), patient risk factors (e.g. co-morbidities, medications) and treatment factors (grade of doctor, therapies initiated during hospital stay). Main Outcomes include treatment time (time from first ENT review to time haemostasis was achieved and patient was safe for hospital discharge) and 30-day hospital readmission rate. RESULTS: 834 patients had sufficient data for inclusion. Patients who did not receive nasal cautery at first specialist review had a treatment time greater than double the time of those who were cauterised: Adjusted ratio (aR) 2.5 (95% CI 1.7-3.3), after controlling for age, bleeding severity, and whether they received a nasal pack or not. Only 30% of patients received management that complied with new national guidance, but those that did were 87% more likely to be achieve haemostasis before those that did not, even after controlling for bleeding severity. Type of treatment, whether initial intervention or management strategy, did not affect 30-day re-attendance. CONCLUSIONS: Analysis of national audit data suggest that cautery at first specialist review, and management according to national guidance can reduce hospital treatment times without compromising 30-day re-attendance. Future work should investigate why early nasal cautery is infrequently used, and how service delivery can be optimised to allow widespread implementation of evidence-based management for epistaxis.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Mehta N, Stevens K, Smith ME, et al. National prospective observational study of inpatient management of adults with epistaxis - a National Trainee Research Collaborative delivered investigation. Rhinology. 2019. PMID: 30610832. doi:10.4193/Rhin18.239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。